Concurrent medications and medical conditions: Patients taking GLP-1 medications often have multiple comorbidities and take other medications that may affect respiratory function
In the search for answers, medical research has increasingly focused on the microscopic powerhouses of our cells: the mitochondria
her A1C, a measure of blood sugar, was also teetering into prediabetic territory
The reality is that appetite, satiety, fat burning, and fat storage involve very complex physiological processes that can be affected by a wide variety of factors
Because excess weight is closely linked to insulin resistance, fatty liver disease, sleep apnoea, cardiovascular disease, and progression to type 2 diabetes, weight loss achieved with GLP-1 therapy can have wide-ranging metabolic benefits even before diabetes develops
Correct application meaningfully affects both efficacy and tolerability